abstract |
"IMMEDAZOES REPLACED AS TAFIA INHIBITORS". The present invention provides compounds of formula (I). These compounds are a class of atherosclerosis TAFIa inhibitors, adhesions, dermal scars, cancer, fibrotic conditions, inflammatory diseases, and those conditions that benefit from maintaining or increasing bradykinin levels in the body. |